Allscripts upgraded to Strong Buy from Market Perform at Raymond James

theflyonthewall.com

Raymond James upgraded Allscripts due to expectations for stable Q4 earnings results, new management catalysts, new product launches, and valuation. Price target is $13.

Rates

View Comments